Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives

@article{Shimazu2004PharmacologicalSW,
  title={Pharmacological studies with endogenous enhancer substances: $\beta$-phenylethylamine, tryptamine, and their synthetic derivatives},
  author={Seiichiro Shimazu and Ildikó Miklya},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={2004},
  volume={28},
  pages={421-427}
}
  • S. Shimazu, I. Miklya
  • Published 1 May 2004
  • Biology, Chemistry
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
The potential of trace amines and their receptors for treating neurological and psychiatric diseases.
  • M. D. Berry
  • Biology
    Reviews on recent clinical trials
  • 2007
TLDR
The aim of the current article is to review the previous studies linking trace amines to human pathology in the context of the recently discovered trace amine receptors and evidence of the existence of Trace amine receptor polymorphisms and mutations associated with such disorders.
Investigation of trace amine receptors in the cardiovascular systems
TLDR
The molecular biological confirmation of the presence of TAAR1 and the pharmacological findings regarding the effects of TAs in rat aortic rings might explain their hypertensive effects and their role in coronary heart disease and migraine headache.
Synephrine: from trace concentrations to massive consumption in weight-loss.
The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review
Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond
TLDR
It is believed that migraine attacks derive from a top-down dysfunctional process that initiates in a hyperexcitable and hypoenergetic brain in the frontal lobe and downstream in abnormally activated nuclei of the pain matrix.
Effect of orange juice and tryptamine on the behavior and c-fos expression of Wistar rats
TLDR
The chronic and lengthy consumption of orange juice or their derivatives in the diet could be a factor responsible to induce mood disorders and may promote excess caloric consumption.
Receptors of mammalian trace amines
  • A. Lewin
  • Biology, Psychology
    The AAPS Journal
  • 2008
TLDR
Observations associated with the distribution of trace amine associated receptors suggest that they may be involved in depression, attention-deficit hyperactivity disorder, eating disorders, migraine headaches, and Parkinson's disease.
Receptors of Mammalian Trace Amines
TLDR
Observations associated with the distribution of trace amine associated receptors suggest that they may be involved in depression, attention-deficit hyperactivity disorder, eating disorders, migraine headaches, and Parkinson's disease.
...
...

References

SHOWING 1-10 OF 58 REFERENCES
(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain.
  • J. Knoll
  • Biology, Psychology
    Pharmacology & toxicology
  • 1998
TLDR
It may be supposed that a prophylactic low dose administration of a safe catecholaminergic activity enhancer substance during the postdevelopmental phase of life will slow the age-related decline of behavioral performances, delay natural death and decrease susceptibility to Parkinson's disease and Alzheimer's disease.
Enhancer Regulation/Endogenous and Synthetic Enhancer Compounds: A Neurochemical Concept of the Innate and Acquired Drives
  • J. Knoll
  • Biology
    Neurochemical Research
  • 2004
TLDR
Experimental evidence and clinical data are summarized supporting the proposal that, due to the progressive decay of the mesencephalic enhancer regulation with the passing of time, the prophylactic administration of a synthetic enhancer substance during postdevelopmental life could significantly slow the age-related decay of behavioral performances, prolong life, and prevent the precipitation or delay the onset of Parkinson's disease and Alzheimer's disease.
Functional interactions of 2-phenylethylamine and of tryptamine with brain catecholamines: Implications for psychotherapeutic drug action
  • A. Greenshaw
  • Psychology, Biology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1989
Does phenylethylamine act as an endogenous amphetamine in some patients?
TLDR
The importance of phenylethylamine in mental disorders is far from fully elucidated but the evolution of Phenylethyamine concentrations in relation to symptoms remains a worthwhile investigation for individual psychotic patients.
...
...